Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Tirofiban | hsa00440 | Phosphonate and phosphinate metabolism | 2.16E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Tirofiban | hsa00564 | Glycerophospholipid metabolism | 2.52E-02 | 3 | P48651, Q9Y6K0, Q86XP1 | PTDSS1, CEPT1, DGKH | More | | Tirofiban | hsa00565 | Ether lipid metabolism | 4.27E-02 | 1 | Q9Y6K0 | CEPT1 | More | | Tirofiban | hsa00670 | One carbon pool by folate | 1.32E-02 | 1 | P00374 | DHFR | More | | Tirofiban | hsa00740 | Riboflavin metabolism | 2.16E-02 | 1 | Q969G6 | RFK | More | | Tirofiban | hsa00785 | Lipoic acid metabolism | 4.27E-02 | 1 | Q9Y234 | LIPT1 | More | | Tirofiban | hsa00790 | Folate biosynthesis | 1.32E-02 | 1 | P00374 | DHFR | More | | Tirofiban | hsa00983 | Drug metabolism - other enzymes | 3.10E-02 | 2 | P20839, Q16772 | IMPDH1, GSTA3 | More | | Tirofiban | hsa01100 | Metabolic pathways | 2.79E-02 | 14 | Q9Y234, Q16772, Q02153, P20839, O94777, Q9Y6K0, Q86XP1, Q9UHK6, Q86VZ5, P48651, Q969G6, P14927, Q06055, Q9NVH6 | LIPT1, GSTA3, GUCY1B3, IMPDH1, DPM2, CEPT1, DGKH, AMACR, SGMS1, PTDSS1, RFK, UQCRB, ATP5G2, TMLHE | More | | Tirofiban | hsa01240 | Biosynthesis of cofactors | 1.75E-02 | 2 | Q969G6, Q9Y234 | RFK, LIPT1 | More | | Tirofiban | hsa01523 | Antifolate resistance | 1.98E-02 | 1 | P00374 | DHFR | More | | Tirofiban | hsa01524 | Platinum drug resistance | 4.57E-02 | 1 | P20585 | MSH3 | More | | Tirofiban | hsa03420 | Nucleotide excision repair | 4.91E-02 | 2 | P07992, P54727 | ERCC1, RAD23B | More | | Tirofiban | hsa03430 | Mismatch repair | 3.93E-02 | 1 | P20585 | MSH3 | More | | Tirofiban | hsa04015 | Rap1 signaling pathway | 2.26E-02 | 3 | P25116, Q8TEU7, P08514 | F2R, RAPGEF6, ITGA2B | More | | Tirofiban | hsa04022 | cGMP-PKG signaling pathway | 1.05E-02 | 3 | P24844, Q8WYR1, Q15746 | MYL9, PIK3R5, MYLK | More | | Tirofiban | hsa04024 | cAMP signaling pathway | 1.40E-02 | 3 | P48058, P25116, P24844 | GRIA4, F2R, MYL9 | More | | Tirofiban | hsa04071 | Sphingolipid signaling pathway | 4.56E-02 | 6 | Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Tirofiban | hsa04270 | Vascular smooth muscle contraction | 4.65E-02 | 2 | Q15746, P24844 | MYLK, MYL9 | More | | Tirofiban | hsa04330 | Notch signaling pathway | 4.91E-02 | 2 | P49768, P78504 | PSEN1, JAG1 | More | | Tirofiban | hsa04340 | Hedgehog signaling pathway | 3.46E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Tirofiban | hsa04510 | Focal adhesion | 3.36E-02 | 3 | P08514, Q15746, P24844 | ITGA2B, MYLK, MYL9 | More | | Tirofiban | hsa04512 | ECM-receptor interaction | 2.44E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Tirofiban | hsa04514 | Cell adhesion molecules | 4.65E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Tirofiban | hsa04520 | Adherens junction | 4.91E-02 | 2 | P07947, P19784 | YES1, CSNK2A2 | More | | Tirofiban | hsa04530 | Tight junction | 7.42E-04 | 4 | Q8TEU7, O00501, Q14247, P24844 | RAPGEF6, CLDN5, CTTN, MYL9 | More | | Tirofiban | hsa04610 | Complement and coagulation cascades | 2.94E-02 | 2 | P25116, P10909 | F2R, CLU | More | | Tirofiban | hsa04611 | Platelet activation | 1.59E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Tirofiban | hsa04612 | Antigen processing and presentation | 2.40E-02 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Tirofiban | hsa04613 | Neutrophil extracellular trap formation | 3.61E-02 | 13 | O60603, P05164, P08246, Q9UM07, Q6FI13, Q15080, P20160, P08311, O75015, P21730, P21462, O43315, Q16539 | TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, NCF4, AZU1, CTSG, FCGR3B, C5AR1, FPR1, AQP9, MAPK14 | More | | Tirofiban | hsa04621 | NOD-like receptor signaling pathway | 2.62E-02 | 11 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Tirofiban | hsa04622 | RIG-I-like receptor signaling pathway | 1.63E-02 | 2 | Q12933, P10145 | TRAF2, IL8 | More | | Tirofiban | hsa04657 | IL-17 signaling pathway | 3.91E-02 | 7 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF | More | | Tirofiban | hsa04658 | Th1 and Th2 cell differentiation | 1.12E-02 | 8 | Q04759, P20963, P09693, Q16539, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, MAPK14, STAT4, GATA3, TBX21, HLA-DOB | More | | Tirofiban | hsa04660 | T cell receptor signaling pathway | 3.76E-03 | 11 | P01375, Q9UDY8, Q04759, O95267, Q08881, P20963, P09693, P01732, Q13191, Q16539, P49841 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, CBLB, MAPK14, GSK3B | More | | Tirofiban | hsa04724 | Glutamatergic synapse | 2.94E-02 | 2 | P48058, Q9NSB8 | GRIA4, HOMER2 | More | | Tirofiban | hsa04810 | Regulation of actin cytoskeleton | 1.38E-03 | 4 | P24844, Q15746, P08514, P25116 | MYL9, MYLK, ITGA2B, F2R | More | | Tirofiban | hsa04921 | Oxytocin signaling pathway | 6.37E-03 | 3 | Q15746, P24844, Q8WYR1 | MYLK, MYL9, PIK3R5 | More | | Tirofiban | hsa05130 | Pathogenic Escherichia coli infection | 2.51E-02 | 3 | Q14247, O00501, P25116 | CTTN, CLDN5, F2R | More | | Tirofiban | hsa05140 | Leishmaniasis | 1.87E-02 | 7 | P13612, O75015, P13765, O60603, P01375, Q16539, Q15080 | ITGA4, FCGR3B, HLA-DOB, TLR2, TNF, MAPK14, NCF4 | More | | Tirofiban | hsa05144 | Malaria | 1.17E-02 | 3 | P68871, P05107, P10145 | HBB, ITGB2, IL8 | More | | Tirofiban | hsa05146 | Amoebiasis | 3.91E-02 | 7 | P09341, P27930, P01375, O60603, P05089, P22694, P08311 | CXCL1, IL1R2, TNF, TLR2, ARG1, PRKACB, CTSG | More | | Tirofiban | hsa05200 | Pathways in cancer | 3.23E-02 | 2 | P17301, P20585 | ITGA2, MSH3 | More | | Tirofiban | hsa05202 | Transcriptional misregulation in cancer | 3.00E-02 | 13 | P14780, P27930, Q15744, Q16548, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P12980, P24522 | MMP9, IL1R2, CEBPE, BCL2A1, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, LYL1, GADD45A | More | | Tirofiban | hsa05310 | Asthma | 2.81E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Tirofiban | hsa05321 | Inflammatory bowel disease | 3.16E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Tirofiban | hsa05332 | Graft-versus-host disease | 3.46E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | Tirofiban | hsa05410 | Hypertrophic cardiomyopathy | 2.63E-02 | 1 | P17301 | ITGA2 | More | | Tirofiban | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.98E-02 | 1 | P17301 | ITGA2 | More | | |